Literature DB >> 24618534

Pericardial effusion in pulmonary arterial hypertension.

Sandeep Sahay1, Adriano R Tonelli.   

Abstract

Abstract Pulmonary arterial hypertension (PAH) is a serious condition that can lead to right heart failure and death. Pericardial effusion in PAH is associated with significant morbidity and mortality, and its pathogenesis is complex and poorly understood. There are few data on the prevalence of pericardial effusion in PAH, and more importantly, the management of pericardial effusion is controversial. Current literature abounds with case reports, case series, and retrospective studies that have limited value for assessing this association. Hence, we summarize the available evidence on this ominous association and identify areas for future research.

Entities:  

Year:  2013        PMID: 24618534      PMCID: PMC4070800          DOI: 10.1086/674302

Source DB:  PubMed          Journal:  Pulm Circ        ISSN: 2045-8932            Impact factor:   3.017


  43 in total

Review 1.  Acute cardiac tamponade.

Authors:  David H Spodick
Journal:  N Engl J Med       Date:  2003-08-14       Impact factor: 91.245

Review 2.  Pericardial diseases.

Authors:  David M Dudzinski; Gary S Mak; Judy W Hung
Journal:  Curr Probl Cardiol       Date:  2012-03       Impact factor: 5.200

3.  Clinical differences between idiopathic and scleroderma-related pulmonary hypertension.

Authors:  Micah R Fisher; Stephen C Mathai; Hunter C Champion; Reda E Girgis; Traci Housten-Harris; Laura Hummers; Jerry A Krishnan; Fredrick Wigley; Paul M Hassoun
Journal:  Arthritis Rheum       Date:  2006-09

Review 4.  Updated clinical classification of pulmonary hypertension.

Authors:  Gérald Simonneau; Ivan M Robbins; Maurice Beghetti; Richard N Channick; Marion Delcroix; Christopher P Denton; C Gregory Elliott; Sean P Gaine; Mark T Gladwin; Zhi-Cheng Jing; Michael J Krowka; David Langleben; Norifumi Nakanishi; Rogério Souza
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094

5.  Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.

Authors:  Anna Fijalkowska; Marcin Kurzyna; Adam Torbicki; Grzegorz Szewczyk; Michal Florczyk; Piotr Pruszczyk; Monika Szturmowicz
Journal:  Chest       Date:  2006-05       Impact factor: 9.410

6.  Echocardiographic features of primary pulmonary hypertension.

Authors:  D J Goodman; D C Harrison; R L Popp
Journal:  Am J Cardiol       Date:  1974-03       Impact factor: 2.778

Review 7.  Cardiac tamponade and large pericardial effusions in systemic sclerosis: a report of four cases and a review of the literature.

Authors:  James V Dunne; Julie P Chou; Mohan Viswanathan; Pearce Wilcox; Simon H Huang
Journal:  Clin Rheumatol       Date:  2011-01-14       Impact factor: 2.980

8.  Severe rheumatic mitral stenosis with pericardial effusion causing left ventricular tamponade.

Authors:  S W Davies; A Youhana; M Copp
Journal:  Br Heart J       Date:  1992-03

9.  Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension.

Authors:  Ronald J Raymond; Alan L Hinderliter; Park W Willis; David Ralph; Edgar J Caldwell; William Williams; Neil A Ettinger; Nicholas S Hill; Warren R Summer; Bennett de Boisblanc; Todd Schwartz; Gary Koch; Linda M Clayton; Maria M Jöbsis; James W Crow; Walker Long
Journal:  J Am Coll Cardiol       Date:  2002-04-03       Impact factor: 24.094

10.  Pulmonary hypertension decreases the predictive accuracy of echocardiographic clues for cardiac tamponade.

Authors:  G D Plotnick; D C Rubin; Z Feliciano; A A Ziskind
Journal:  Chest       Date:  1995-04       Impact factor: 9.410

View more
  7 in total

1.  Long-Term Survival of Patients with Pulmonary Arterial Hypertension at a Single Center in Taiwan.

Authors:  Le-Yung Wang; Kuang-Tso Lee; Chia-Pin Lin; Lung-An Hsu; Chun-Li Wang; Tsu-Shiu Hsu; Wan-Jing Ho
Journal:  Acta Cardiol Sin       Date:  2017-09       Impact factor: 2.672

Review 2.  How to interpret a paediatric echocardiography report.

Authors:  N Forshaw; M Broadhead; M Fenton
Journal:  BJA Educ       Date:  2020-07-02

Review 3.  Imaging of pulmonary hypertension: an update.

Authors:  Harold Goerne; Kiran Batra; Prabhakar Rajiah
Journal:  Cardiovasc Diagn Ther       Date:  2018-06

4.  Effects of Single Drug and Combined Short-term Administration of Sildenafil, Pimobendan, and Nicorandil on Right Ventricular Function in Rats With Monocrotaline-induced Pulmonary Hypertension.

Authors:  Telma M Nakata; Ryou Tanaka; Rieko Yoshiyuki; Toshiharu Fukayama; Seijiro Goya; Ryuji Fukushima
Journal:  J Cardiovasc Pharmacol       Date:  2015-06       Impact factor: 3.105

5.  Left ventricular tamponade- pathophysiology determines the therapeutic approach: a case series.

Authors:  Barun Kumar; Ashwin Kodliwadmath; Anupam Singh; Amar Upadhyay; Anshuman Darbari; Bhanu Duggal
Journal:  Eur Heart J Case Rep       Date:  2020-12-11

6.  E-REVEAL Lite 2.0 scoring for early prediction of disease progression in pulmonary arterial hypertension.

Authors:  Sandeep Sahay; Jiken Bhatt; Sarah Beshay; Ashrith Guha; Duc T Nguyen; Edward A Graviss; Sherif F Nagueh
Journal:  Pulm Circ       Date:  2022-01-12       Impact factor: 2.886

Review 7.  New Approaches to Management of Pericardial Effusions.

Authors:  George Lazaros; Charalambos Vlachopoulos; Emilia Lazarou; Konstantinos Tsioufis
Journal:  Curr Cardiol Rep       Date:  2021-07-01       Impact factor: 2.931

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.